Joy Artin, et al. “Proprotein Convertase Subtilisin Kexin 9 (PCSK9) in Patients With Diffuse Systemic Sclerosis: A Marker of Disease Activity and Severe Disease Manifestations With Potential Therapeutic Implementations”. Archives of Rheumatology, vol. 38, no. 2, June 2023, pp. 249-56, doi:10.46497/ArchRheumatol.2023.9638.